ABCB1

Chr 7AR

ATP binding cassette subfamily B member 1

Also known as: ABC20, CD243, CLCS, ENPAT, GP170, MDR1, P-GP, PGY1

The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017]

Primary Disease Associations & Inheritance

{Colchicine resistance}MIM #120080
{Inflammatory bowel disease 13}MIM #612244
Encephalopathy, acute transientMIM #620950
AR
0
ClinVar variants
0
Pathogenic / LP
0.00
pLI score
12
Active trials
Clinical SummaryABCB1
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.33) despite low pLI — interpret in context.
💊
Clinical Trials
12 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.47LOEUF
pLI 0.000
Z-score 4.98
OE 0.33 (0.230.47)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
1.44Z-score
OE missense 0.85 (0.790.91)
579 obs / 685.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.33 (0.230.47)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.85 (0.790.91)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.1.02
01.21.6
LoF obs/exp: 21 / 64.0Missense obs/exp: 579 / 685.1Syn Z: -0.19

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

ABCB1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

{Colchicine resistance}

MIM #120080

Molecular basis of disorder known

{Inflammatory bowel disease 13}

MIM #612244

Molecular basis of disorder known

Encephalopathy, acute transient

MIM #620950

Molecular basis of disorder known

Autosomal recessive
Clinical Literature
Landmark / reviewRecent case evidence

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Kidney Transplant Failure and RejectionImmunosuppression-related Infectious Disease

Tacrolimus Pharmacokinetic Subpopulations

RECRUITING
NCT04526431University Hospital, GrenobleStarted 2020-07-28
Dosage Forms Oral
Acute Myeloid Leucemia

Single Cell Acute Leukemia Analysis

NOT YET RECRUITING
NCT06906978Phase NAAssistance Publique Hopitaux De MarseilleStarted 2025-07-31
blood sampling
Coronary Disease

Genetic Polymorphism Associated With Coronary Heart Disease Susceptibility and Variability of Clopidogrel Response

ACTIVE NOT RECRUITING
NCT03373552Hôpital Universitaire Fattouma BourguibaStarted 2015-08-12
Platelet function assay
Parkinson Disease

Aquaporin-4 Single Nucleotide Polymorphisms in Patients With Idiopathic and Familial Parkinson's Disease

ACTIVE NOT RECRUITING
NCT04553185University of ExeterStarted 2018-11-28
Study procedure
Pharmacokinetics of Celecoxib in Children

CELECOXIB Plasma and Cerebral Spinal Fluid Pharmacokinetics in Children

RECRUITING
NCT01344200Phase PHASE2Children's Hospital of Eastern OntarioStarted 2024-01-29
CelecoxibPlacebo
Kawasaki DiseaseCoronary Artery Aneurysm

Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease

RECRUITING
NCT05643651Phase PHASE4Children's Hospital of Fudan UniversityStarted 2025-06-01
Rivaroxaban Oral Tablet [Xarelto]Aspirin or ClopidogrelWarfarin
Epilepsy

Precision Medicine in the Treatment of Epilepsy

RECRUITING
NCT05450822Gitte Moos KnudsenStarted 2022-02-18
LevetiracetamLevetiracetam TabletsLamotrigine tablet
AnalgesiaCardiac Surgery

Precision Analgesia for Cardiac Surgery

NOT YET RECRUITING
NCT05612399Kathirvel SubramaniamStarted 2026-04-01
Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))Peripheral Artery Disease

REGistry of Long-term AnTithrombotic TherApy-1

RECRUITING
NCT04347200National Medical Research Center for Cardiology, Ministry of Health of Russian FederationStarted 2015-01-15
Antiplatelet Drug
Combined Analysis of Polymorphisms and Dabigatran Pharmacokinetic Parameters

Population Pharmacokinetic Study of the Effect of Polymorphisms in the ABCB1 and CES1 Genes on the Pharmacokinetics of Dabigatran

NOT YET RECRUITING
NCT06387407The Affiliated Hospital Of Guizhou Medical UniversityStarted 2024-05-01
Dabigatran Etexilate 150mg
Leukemia

Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia

ACTIVE NOT RECRUITING
NCT00898456Alliance for Clinical Trials in OncologyStarted 2006-10
gene expression analysismolecular genetic techniquepolymorphism analysis
Patients With Schizophrenia

PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia

NOT YET RECRUITING
NCT05839613Phase NAAssistance Publique Hopitaux De MarseilleStarted 2023-05
Therapeutic Drug Monitoring (TDM) and Pharmacogenetics (PG)